Xencor (XNCR) Cash from Financing Activities (2013 - 2026)

Xencor (XNCR) reported Cash from Financing Activities of $950000.0 for Q1 2026, down 23.94% year-over-year from $1.2 million in Q1 2025, and down 84.97% quarter-over-quarter from $6.3 million in Q4 2025.

Xencor (XNCR) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash from Financing Activities data on file, last reported at $950000.0 in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $950000.0, down 23.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (down 95.97% YoY), and the FY2025 annual result was $8.2 million, down 95.82% from the prior year.
  • Cash from Financing Activities slipped to $950000.0 in Q1 2026 per XNCR's latest filing, from $6.3 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $189.9 million in Q3 2024 and troughed at $356000.0 in Q3 2023.
  • A 5-year average of $25.1 million and a median of $1.3 million in 2022 frame the typical range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 53232.58% in 2024 and fell as far as 97.62% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.2 million in 2022, then jumped by 15785.57% to $186.0 million in 2023, then slumped by 97.62% to $4.4 million in 2024, then jumped by 42.65% to $6.3 million in 2025, then slumped by 84.97% to $950000.0 in 2026.
  • Business Quant data shows XNCR's Cash from Financing Activities at $950000.0 in Q1 2026, $6.3 million in Q4 2025, and $662000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Xencor 953.38 Mn 878.64 Mn - 950,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 950,000.00
Mar 31, 2026 950,000.00
Dec 31, 2025 6.32 Mn
Dec 31, 2025 6.32 Mn
Jun 30, 2025 662,000.00
Jun 30, 2025 662,000.00
Mar 31, 2025 1.25 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 4.43 Mn
Dec 31, 2024 4.43 Mn
Sep 30, 2024 189.86 Mn
Sep 30, 2024 189.86 Mn
Jun 30, 2024 1.07 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 1.79 Mn
Mar 31, 2024 1.79 Mn
Dec 31, 2023 186.02 Mn
Dec 31, 2023 186.02 Mn
Sep 30, 2023 356,000.00
Sep 30, 2023 356,000.00